Optimising the performance and interpretation of small bowel capsule endoscopy by Beg, Sabina et al.
Optimising the performance and interpretation of Small Bowel Capsule Endoscopy 
Authors: 
Dr Sabina Beg, Gastroenterology, NIHR Nottingham Digestive Diseases Biomedical Research 
Centre, Queens Medical Centre campus, Nottingham University Hospitals NHS Trust, 
Nottingham, NG7 2UH, UK 
Dr Adolfo Parra-Blanco, Gastroenterology, NIHR Nottingham Digestive Diseases Biomedical 
Research Centre, Queens Medical Centre campus, Nottingham University Hospitals NHS 
Trust, Nottingham, NG7 2UH, UK 
 Professor Krish Ragunath, Gastroenterology, NIHR Nottingham Digestive Diseases 
Biomedical Research Centre, Queens Medical Centre campus, Nottingham University 
Hospitals NHS Trust, Nottingham, NG7 2UH, UK 
Author Contributions: 
Sabina Beg reviewed the evidence and produced the manuscript of this review. Dr Para 
Blanco and Prof Ragunath supervised this project and finalised the manuscript. 
Supportive Foundations: Not applicable  
Licence for Publication 
The Corresponding Author has the right to grant on behalf of all authors and does grant on 
behalf of all authors, an exclusive licence (or non exclusive for government employees) on a 
worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be 
published in FG and any other BMJPGL products and sublicences such use and exploit all 
subsidiary rights, as set out in our licence 
(http://group.bmj.com/products/journals/instructions-for-authors/licence-forms). 
Competing Interests 
Professor K Ragunath has received research funding from; 
Olympus: Research Grants, Consultancy, Educational grants 
Medtronics: Educational grants 
Intromedic: Research Grant 
  
Correspondence to: 
Professor Krish Ragunath, MD, Professor of Gastro-Intestinal Endoscopy  
Gastroenterology,  
NIHR Nottingham Digestive Diseases Biomedical Research Centre 
Queens Medical Centre, Nottingham,  
NG7 2UH, UK 
k.ragunath@nottingham.ac.uk 
tel: +441159249924, fax: +44115942223 
 
 
 
 
 
Abstract 
Small bowel capsule endoscopy has become a commonly used tool in the investigation of 
gastrointestinal symptoms and is now widely available in clinical practice. In contrast to 
conventional endoscopy, there is a lack of clear consensus on when competency is achieved 
or the way in which capsule endoscopy should be performed in order to maintain quality and 
clinical accuracy. Here we explore the evidence on the key factors that influence the quality 
of small bowel capsule endoscopy services. 
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Introduction 
Since its introduction at the turn of the millennium, small bowel capsule endoscopy (SBCE) 
has offered a non-invasive, acceptable and well tolerated means of examining the entirety of 
the small bowel [1]. A patient is simply required to swallow the capsule, which then passively 
passes through the gastrointestinal tract whilst acquiring images. These images are then later 
reviewed and interpreted. SBCE has become an established investigative modality for occult 
gastrointestinal bleeding and recurrent iron deficiency anaemia where bi-directional 
endoscopy has failed to reveal a cause, suspected small bowel Crohn’s disease and in the 
surveillance of polyposis syndromes [2-4]. The availability of device assisted enteroscopy 
means that identified lesions can be investigated further and potentially treated 
endoscopically. As a result there has been an expansion of SBCE services globally. Despite this 
there still remains ambiguity on the optimal way in which SBCE should be read in order to 
ensure quality. In contrast to conventional endoscopy, at present there is no clear consensus 
on factors that lead to competence or how to monitor performance in SBCE. Here we review 
the evidence in order to answer the key questions that affect the performance and 
interpretation of SBCE. 
  
What is the most effective way to prepare the small bowel prior to capsule endoscopy? 
In common with conventional endoscopy, adequate mucosal views are required to make an 
accurate diagnosis. Complete cleansing of the small bowel is challenging due to the constant 
secretion of gastric, biliary and pancreatic fluids. This is further compounded by the passive 
nature of SBCE, which does not allow for the flushing or suctioning of bubbles and debris. 
There are numerous studies examining the impact of purgatives on mucosal cleansing, with 
conflicting results. Several meta-analyses have pooled the results of these studies and suggest 
that the use of polyethylene glycol (PEG) is superior to a clear liquid diet alone [5-7]. A PEG 
preparation lends itself as an ideal candidate for intestinal lavage, as this is a transparent 
solution, the mucosa can be visualised through any residual fluid. Further, it has been proven 
to be more effective than available alternatives such as sodium phosphate regimes [6]. When 
volume was evaluated, there was no benefit in terms of cleansing or diagnostic yield with the 
use of a 4 litre PEG regime over 2 litres, with the latter being more patient friendly [8, 9].  
One study examines the effect of the timing of bowel preparation, concluding that there was 
improved mucosal visibility when using a split dose regime with the last litre of PEG given 4 
hours pre-procedure rather than 10 hours [10].  A pilot study aimed to overcome the common 
problem of poor distal views, by using a ‘booster’ consisting of a single sachet of Picolax 
administered one hour after the capsule is swallowed, following  the consumption of clear 
fluids without purgatives during the previous day. Although a statistically significant 
difference in the number of lesions was not demonstrated when compared to a 2L PEG 
regime, distal views were improved, with the potential to offer a cheaper and more tolerable 
preparation regime [11]. 
In selected cases, it may be appropriate to forgo bowel preparation. Where patients are 
admitted with acute suspected small bowel bleeding it is known that a positive diagnosis is 
more likely to be made if this test is performed within a short period of the bleeding episode 
[12-14]. As the location of bleeding is the primary point of interest, rather than subtle mucosal 
pathology, the administration of preparation may result in a delay without a clear clinical 
benefit. 
Antifoaming agents such as Simethicone have been proposed as a premedication to disperse 
bubbles, commonly encountered in the duodenum. This has been trialled with good effect, 
having been found to provide superior views of the proximal small bowel compared to a clear 
liquid diet alone [15]. Where antifoaming agents were combined with bowel preparation an 
improvement in visualisation was observed [3, 16-18].  
The battery life of the first generation of capsules were limited to 8 hours, leading to a 
proportion of studies where the caecum was not reached. In order to overcome this potential 
limitation the concept of increasing the transit speed through the gastrointestinal tract with 
pro-kinetics was introduced. This appears to have a positive effect on completion rates with 
no deleterious effect on diagnostic yield [19]. However, in the current era of capsules with 
minimum recording times of 12 hours, routine use of pro-kinetics is rarely required and is 
usually limited to cases where the capsule has failed to exit the stomach after one hour [20]. 
 
 
 
 
Which capsule endoscopy system should be used? 
At present there are five commercially available SBCE systems; PillCam (Given Imaging), 
EndoCapsule (Olympus), MiroCam (Medtronic), CapsoCam (CapsoVision) and OMOM 
(Chongqing Jinshan Science & Technology). Each of these share the same core components, 
which include; an imaging device, a lens, a light source and a battery, all of which are encased 
within a non-biodegradable toughened plastic casing. In all but one system (CapsoCam), 
images acquired from the capsule are transmitted wirelessly to a receiving device, before 
being uploaded and read at a workstation using proprietary software. Differences in the 
design and technical capabilities of these components leads to subtle differences in capsule 
specification, as summarised in the Table 1. 
 
As first to the market the PillCam is the most widely used in clinical practice and studied in 
the literature. This system is now in its third generation (PillCam SB3), boasting improved 
image resolution and an adaptive frame rate, which increases from 2fps to 6 fps when the 
capsule is sensed to be moving at a high velocity. The EndoCapsule system followed shortly 
afterwards in 2004, offering a 3D tracking function to enable the localisation of detected 
lesions in order to guide therapeutic approach where this is required. 
The MiroCam capsule uses electric field propagation, which exploits the patients’ body as a 
conductor for data transmission. This reduces energy consumption compared to radio-
frequency based systems, enabling a long battery life in spite of its smaller dimensions [21].  
MiroCam offer also magnetically steerable capsule (Mirocam Navi) designed for examination 
of the upper gastro-intestinal tract is available, but at present its use is limited to the research 
setting.[22, 23] 
CapsoCam is able to offer a 360 degree ‘panoramic’ view, owing to four laterally placed 
cameras. This may have the potential to result in a greater diagnostic yield through an 
increased number of images, although this needs to be offset against longer reading times 
[24-26]. The images acquired are stored within the capsule and so a receiving device is not 
required. Retrieval of the capsule following expulsion from the body is necessary, with a 
magnetic wand provided to aid recovery. This could be advantageous in rural settings, where 
patients may not be able to attend a hospital but could send and receive equipment through 
the post. However, this is clearly not suitable for all patients, with a proportion unable to 
retrieve the capsule in an observational study [27]. 
The OMOM capsule has been in used for many years and is well established in China and Asia, 
but has only been recently available in the USA and Europe. This capsule boasts duplex data 
communication, where the endoscopic view can be evaluated, allowing for real time 
adjustments of parameters such as frame rate, brightness and exposure in order to optimise 
the quality of the examination.  
There are few head to head trials comparing the clinical implications of using one capsule 
versus another (Table 2) [3]. Where these exist, no significant differences have been 
demonstrated. Which capsule endoscopy system is used, is therefore determined by user 
preference, with cost and procurement undoubtedly influencing these decisions.  
Table 1: Specifications of the commercially available capsule endoscopy systems 
Model Company Dimensions 
(mm) 
Weight 
(grams) 
Field of view 
(degrees) 
Frames per 
second 
Image sensor Transmission Battery life  
(hours) 
PillCam (SB3) 
 
Given 
Imaging 
26x11 1.9 156 2-6 CMOS Radio-frequency 11 
MiroCam Intromedic 24x11 3.25 170 3 CMOS Electrical field 
propagation 
12 
Endocapsule (EC-
10) 
 
Olympus 26x11 3.3 160 2 CMOS Radio-frequency 12 
OMOM (2) 
 
Jianshan 28x13 4.5 140 2 CMOS Radio-frequency 10 
CapsoCam (SV2) 
 
Capsovision 31x11 4 360 
(laterally) 
20 CMOS Images stored 15 
 
 
 
 
Table 2: Head to head trial comparing different capsule endoscopy systems 
Study Country Systems 
compared 
No of 
cases 
Study Design End points Summary of results 
Hartmann D et 
al (2007) [28] 
Germany 
(single centre) 
EndoCapsule 
vs PillCam 
40 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield 
and completion 
rate 
 Higher diagnostic yield in EndoCapsule- 
not statically significant. 
 Higher completion in EndoCapsule 
system (100% vs 82.5%) 
Cave DR et el 
(2008) [29] 
USA 
(multicentre) 
EndoCapsule 
vs PillCam 
51 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield,  
completion rate 
and quality of 
view  
 No significant difference in diagnostic 
yield 
 Subjective judgement in image quality 
favouring EndoCapsule 
Kim HM et al 
(2010) [30] 
Korea  
(single centre) 
MiroCam vs 
PillCam 
24 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield 
and completion 
rate 
 No significant difference in diagnostic 
yield 
 Higher completion in MiroCam system 
(83.3% vs 58.3%) 
Pioche M 
(2011) [31] 
France 
(Multicentre) 
MiroCam vs 
PillCam SB2 
73 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield, 
transit time and 
capsule reading 
time. 
 Statistically non-significant higher yield 
using MiroCam system 
 (95.2% vs 78.6% accuracy in detecting 
lesions) 
Koulaouzidis 
et al (2012) 
[32] 
UK  
(single centre) 
MiroCam vs 
PillCam SB1/2 
619 
 
Retrospective 
analysis (209 
MiroCam, 262 SB1, 
148 SB2) 
Identification of 
the Ampula  
 Ampulla was identified in 9.5%  cases 
 No difference in ampulla detection or 
number of frames in which this was 
visualised between systems 
Hong SP et al 
(2012) [33] 
Korea  
(Single centre) 
MiroCam vs 
PillCam 
141 Retrospective 
analysis (57 studies 
using MiroCam and 
84 using PillCam) 
Visualisation of 
the papillae 
 Higher frequency of papillae detection 
using MiroCam (13.1% vs 29.8%) 
 
Dolak W et al  
(2012)[34]  
Austria 
(single centre) 
 
MiroCam vs 
EndoCapsule 
50 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield 
and completion 
rate 
 No significant difference in diagnostic 
yield 
 No significant difference in completion 
rate 
Choi EH et al 
(2013) [35] 
USA 
(multicentre) 
MiroCam vs 
PillCam 
105 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield 
and completion 
rate 
 No significant difference in diagnostic 
yield 
 Higher completion in MiroCam system 
(93.3% vs 84.3%) 
Pioche M 
(2014) [36] 
France 
(Multicentre) 
CapsoCam vs 
PillCam SB2 
73 Sequential capsules 
(randomly assigned 
order) 
Diagnostic yield  Technical issues with the CapsoCam 
system in 11 patients and with PillCam 
in 2 patients.  
 No significant difference in diagnostic 
yield. 
Who should read and interpret capsule endoscopy cases? 
SBCE does not form a part of the mandatory endoscopy training for gastroenterologists in 
most countries. Those that read capsule are therefore self-selecting, with this skill self-taught 
by interested physicians in a situation where the need for capsule endoscopy services has 
arisen. Studies in assessing accuracy and competence in SBCE are hampered by the fact that 
there is a known significant intra-observer variability, even between experts [37-39]. Further 
in clinical practice it is not always necessary to identify all lesions present in order to arrive at 
the same clinical conclusion. 
In the UK, the British Society of gastroenterology (BSG) does not mandate a minimum 
experience prior to undertaking capsule reading and at present there is no formal 
accreditation process as for other endoscopic procedures. International guidance suggests an 
experience of 10- 25 supervised cases should be performed prior to independent practice. 
These recommendations are largely inferred from secondary findings from studies on training 
in SBCE. A Korean study of 12 gastroenterology trainees specifically set out to determine the 
learning curve in SBCE. By reading one capsule per week, it was shown that it required 11 
weeks to reach kappa coefficients of 0.80 between the trainees and an expert reader [40].  
The Mayo Clinic have developed the only SBCE competence test (CapCT), consisting of three 
elements; a multiple choice quiz on topics pertaining to the use of SBCE, video clips and 
images of pathological findings and finally a formal review of a full capsule case, with 
interpretation of findings and formulation of a management plan. Scores from each 
component are summed, with a requirement to reach at least 82% of the total available score 
of 100 prior to independent practice. When this tool was trialled in a group of 
gastroenterology fellows, who had no prior teaching in capsule endoscopy but were 
experienced in flexible endoscopy, it was found that only those with a prior experience of 21-
35 cases read were able to reach a mean score of 85% after a 4 hour teaching intervention. 
Experienced readers had a mean score of 91% [41].  
 
Training has been proven to be beneficial in the interpretation of SBCE examinations. An 8-
hour hands on training course delivered to 268 participants throughout 4 European countries 
has be evaluated. This demonstrated that 10 twenty-second videos with a range of findings 
were read more accurately following the training course. Where readers had previous capsule 
experience the baseline score was higher compared to novices, however an improvement in 
detection and interpretation was still observed following the intervention [42].  
 
A background in conventional endoscopy appears to correlate with a better ability to 
interpret SBCE. When 10 gastroenterology trainees with experience in flexible endoscopy 
were compared with 5 medical students, it was seen that they were more likely to pick up 
pathology, and less likely to produce false positives [43]. This is corroborated by the findings 
of the European training study, which found prior experience in conventional endoscopy was 
a predictor of better baseline score, independent of the degree of prior capsule experience 
[42]. 
There is increasing interest in employing nurses as physician extenders in the provision of 
endoscopy services. The relatively short learning curve and low risk profile makes SBCE 
particularly appropriate for non-physician reading. Several studies have demonstrated that 
nurses are able to detect lesions accurately in a ‘pre-reading’ capacity [24, 44-50].  
One study estimated adopting this approach would enable a cost saving of as much as $324 
per case read [51]. Observational studies highlight some differences in the way in which 
nurses read, with a greater tendency to mark up more lesions of doubtful significance [46]. 
At present there is insufficient evidence to support the ability of nurses in independent SBCE 
interpretation, including the formulation of a management plan and recommendations. 
 
Which reading settings should be used to interpret capsule endoscopy cases? 
A SBCE study typically results in the acquisition of tens of thousands of images. A clinically 
significant lesion may be present on just a single frame and could therefore be easily missed. 
The likelihood of missing lesions can be influenced by the way in which the capsule study in 
read. Within the various interpretation software programs there is an option to read one 
(Single View: SV), two (Dual View: DV) or four frames (Quad View: QV) as either sequentially 
or overlapping images. Use of QV overlap mode means that any one image is viewed four 
times, as it is seen moving across the screen there is a longer exposure to the image compared 
to SV. The display of the images does however occupy the whole screen, requiring greater 
use of peripheral vision compared to a single central image. In addition the speed at which 
the images are presented (expressed as frames per second) can be adjusted across a 
numerical scale.  
In a recent study evaluation of a single 15 minute video clip containing 60 frames during which 
there was a pathological lesion was performed in 9 different viewing modes; SV at 10 fps, 15 
fps and 25 fps, DV at 10 fps, 15 fps and 25 fps, or QV at 10 fps, 15 fps and 25 fps. This confirmed 
that increased speed was associated with an increased chance of missing lesions. The optimal 
setting was found to be QV overlapping at 10 fps (detecting 51 of the 60 lesions), compared 
to the One image setting at 25fps which detected just 14 [52]. This is supported by a study 
examining the most commonly used reading combinations, which found SV at 25fps had a 
mean diagnostic yield of 26%, compared to 45% when reading SV at 15fps. When four images 
were displayed in the overlap view there was no reduction in accuracy compared to SV at 
15fps, even when increasing the speed to QV 20 fps and even QV 30 fps [53]. 
In daily clinical practice a range of speeds should be used. It is appreciated that the passage 
of a capsule through the duodenum and the proximal jejunum is faster than that through the 
ileum. It is this phenomenon that results in the ampulla, the only landmark within the small 
bowel, to be visualised during just 10% of SBCE examinations [32]. It would therefore be 
prudent to significantly reduce reading speeds during such areas of the small bowel in order 
to increase pathology detection. 
 
Are software enhancements helpful in capsule endoscopy interpretation? 
There has been attempt to exploit advances in information technology to aid the 
interpretation of SBCE, by both enhancing the detection of lesions and by reducing the 
number of normal images reviewed [3, 54]. Given that the movement of a capsule through 
the bowel is non-liner, multiple duplicate images are captured. Removal of such images from 
the reading stream offers the possibility of dramatically reducing reading times. Several 
software algorithms have been developed to remove redundant images and only present 
clinically relevant frames. In clinical practice however the success of this approach has been 
mixed. Whilst reading time is undoubtedly reduced, some studies quote an unacceptably high 
lesion miss rate. This is likely to be due to the capsule software being unable to differentiate 
between subtle mucosal pathology and normal mucosa. The rapid presentation of non- 
sequential images may also be harder to for the viewer to visually process causing relevant 
images to be overlooked.  
 
The PillCam RapidView software offers Quickview, this allows the proportion of images 
excluded to be determined by the reader. Several studies have demonstrated reasonable 
accuracy in the detection of major lesions [55, 56]. When compared to alternate time saving 
strategies this software enhancement proves to be less promising.  Reading in SV or DV at 
20fps was more accurate than the use of Quickview, although not as rapid [57]. Further, it has 
been demonstrated that viewing alternate frames, by adopting the four image sequential 
view and covering half the screen with a piece of paper led to a lower lesion miss rate 
compared to the use of Quickview [58]. Implying that the selection of excluded frames was 
less accurate than random exclusion of half the images. 
 
Similarly the OMOM similar picture elimination software has three modes, with increasing 
proportions of removed images. While each mode reduced reading times, only Mode 1, with 
the least images excluded had a sensitivity greater than 85%, saving a mean reading time of 
9 minutes. 
 
The equivalent EndoCapsule software has been evaluated in a single study comprising of 70 
SBCE cases. This utilised two modes Express Selected, where repeat images are removed and 
Auto Adjust, where the repeated images are maintained within the viewing stream but are 
viewed at an increased speed. One lesion out of the 40 known lesions was missed in either 
time saving mode, leading to an accuracy of 97.5%[59]. This software has been recently 
superseded by Omni-mode, which claims to be able to reduce the images displayed by 65% 
through the ‘intelligent’ removal of repeated as well as overlapping images. To date this has 
been studied in a Japanese multicentre trial, which showed the software was able to correctly 
remove images whilst maintaining all the pre-identified major lesions in 40 selected cases 
[60]. A larger multicentre European study is currently underway. 
 
 
 
 
 
 
 
 Table 3: A summary of the time saving software in the interpretation of small bowel capsule endoscopy 
Study  Country  System  
 
Study Design Summary of results 
Hosoe et al 
(2016) [60] 
Japan  
(Multi centre) 
EndoCapsule: 
Omni-Mode 
 40 pre-selected cases (based on the presence 
of lesions)  
 Each case read twice in Omni mode and twice 
in normal mode 
 Reduction in average reading time from 75 
minutes to 27 minutes. 
 65% reduction in displayed images 
 Sensitivity of 87% 
Subramanian 
et al (2012) 
[59] 
UK 
(Single 
centre) 
EndoCapsule: 
Express 
Selected/ 
Auto Adjust 
 70 capsule cases  
 Read in three mode, Normal (15 fps), Express 
selected + Overview, Adjusted mode + 
Overview 
 Each case read by two independent 
endoscopists  
 Normal: sensitivity of 100%, taking an 
average of 45 mins 
 Express Selected: sensitivity of 97.5%, an 
average 19 mins 
 Auto Adjust sensitivity of 97.5%, an 
average 34mins 
Kyriakos et 
al (2012) [57] 
Greece   
(Single 
Centre) 
Pill Cam: 
QuickView 
 100 capsule studies pre-selected cases 
(based on the presence of lesions)  
 Cases read in 5 different modes, Normal at 10 
fps, Normal at 20 fps, Normal mode with two 
images at 20 fps, Automatic mode 10 fps, 
QuickView at 3 fps 
 All time saving modes were faster than 
reading in Normal mode at 10 fps 
 Best compromise between speed and 
accuracy is Normal mode at 20 fps, with 
either a single or dual image. 
Halling M et 
al (2014) [55] 
Denmark 
(Single 
Centre) 
Pill Cam: 
QuickView 
 Analysis of 12 video clips with findings 
 40 capsules of patients with suspected 
Crohn’s disease 
 Quickview missed 40% of ulcers seen in 
the normal viewing mode 
 This effect is pronounced for terminal ileal 
lesions 
Saurin JC et 
al (2012) [24] 
French 
(multi centre) 
Pill Cam: 
QuickView 
 106 patients recruited across 12 centres 
 Quickview vs normal mode reading 
 94% of significant lesions were identified 
 Mean reading time of 11.6 mins using 
QuickView 
Koulaouzidis 
A et al 
(2012) 
UK (Single 
Centre) 
Pill Cam: 
QuickView 
 Retrospective review of 106 cases 
 Normal mode vs Quickview vs Quickview with 
BM 
 Over 50% of ulcers missed in cases of 
suspect Crohn’s using QuickView 
 64% of potential/bleeding lesions were 
detected in the context of overt/occult 
bleeding 
Shiotani A et 
al (2012) [61] 
Japan 
(Single 
Centre) 
Pill Cam: 
QuickView 
 100 capsule studies read in QuickView vs 
normal reading 
 Unacceptable miss rate 
 Miss rate was greatest in the physicians 
with limited experience. 
 One nurse, two trainees and one experienced 
reader 
Hosoe N 
2012 
Japan 
(Single 
Centre) 
Pill Cam: 
QuickView 
 45 capsule studies 
 Gold standard reading established by two 
experienced readers 
 Three trainees with no prior capsule 
experience read in Normal mode, Automatic 
mode and QuickView. 
 Reduced reading time in automatic and 
QuickView compared to Normal mode 
 179 missed lesions when using QuickView 
Westerhof  et 
al (2009) [58] 
Netherlands 
(Single 
centre) 
Pill Cam: 
QuickView 
 200 cases included  
 First 100 read in Normal mode and then only 
alternate images 
 Second 100 read in Normal mode then with 
QuickView  
 Normal mode average reading time of 17 
mins 
 Miss rate of 4% when viewing alternate 
images. Avreage reading time of 10 mins 
 Miss rate of 13% with QuickView. Average 
reading time of 4.4 mins 
Xu Y et al 
(2014) [62] 
China (single 
centre) 
Omom: 
Similar 
Picture 
Elimination 
 Retrospective study of 148 capsule studies. 
 Read in four modes Normal, Level I, Level II, 
Level III and Level IV 
 Each case read by four independent 
endoscopists 
 Reading time reduction of 25.1-55.0% 
compared with normal mode. 
 Normal: sensitivity of 93.8% 
 Mode I: sensitivity of 87.7% 
 Mode II: sensitivity of 77.8% 
 Mode III: sensitivity of 70% 
 
 
 
 
 
The Suspected Blood Indicator (SBI) is a rapid viewing tool available within the various capsule 
software programs. This highlights frames where an excess number of red pixels have been 
identified and may therefore represent a bleeding lesion. This function is activated by merely 
selecting the SBI mode within the reading software, this results in highlighted frames or 
regions along the scroll bar. In the context of gastrointestinal bleeding, this should obviate 
the need for a complete review of the capsule case, allowing the reader to quickly identify 
lesions and their location. Studies in clinical practice have however been disappointing, with 
reported sensitivities as low as 20% [63] 
A meta-analysis of 16 studies comprising of 2049 patients, confirmed a high sensitivity of 
98.8% in the detection of actively bleeding lesions. This fell to a sensitivity of just 55.3% and 
a specificity of 57.8% in the detection of lesions with bleeding potential that were not actively 
bleeding during the examination. It is noteworthy that the SBI has been trialled exclusively 
using the PillCam capsule software, its utility in in the alternate systems is unknown. 
 
One study attempted to understand the limitations of the SBI with the passage of a capsule 
through an experimental small bowel model. Red lesions were displayed on backgrounds of 
varying colours, commonly encountered in clinical practice. This demonstrated a significantly 
improved likelihood of detecting lesions superimposed on a pale magenta or yellow 
background as compared to pale yellow or brown [64]. As this is a factor that cannot be 
influenced by the operator it remains a major limitation of this approach. 
 
The accuracy of the SBI function is insufficient accurate to allow it use as a time saving 
technique in clinical practice [65]. Instead it could be considered as a useful adjunct to ensure 
no lesions have been missed following initial reading and interpretation. 
 
The use of advanced imaging has become commonplace in the identification and 
characterisation of lesions during endoscopic procedures. This concept has been replicated 
within the PillCam capsule endoscope with the adoption of Flexible Spectral Colour 
Enhancement (FICE). FICE is a post processing visual enhancement technology, which by using 
proprietary software algorithms converts white light images to a restricted range of 
wavelengths in order to enhance mucosal surface pattern. Perhaps due to the lack of control 
and manoeuvrability afforded by flexible endoscopy, the results of SBCE FICE have been 
disappointing. Evaluation across studies showed there was no increase in the detection of 
lesions, although soe settings demonstrated improved lesion delineation [66]. The evidence 
for Blue Mode Imaging is still emerging [67, 68] 
 
Conclusions 
Clear standards in capsule endoscopy reporting are yet to be established. Maintaining the 
diagnostic potential of SBCE requires using this tool effectively. Before a SBCE is undertaken, 
bowel preparation with combined 2 litre PEG preparation and simethicone should be 
considered. Readers should ideally have previous experience of conventional endoscopy and 
undergo formal training and supervised reading of 10-20 cases prior to independent reading. 
Reading with up to 4 frames displayed concurrently at a rate no greater than 15 fps optimises 
the chances of lesion detection. Software enhancements are not sufficiently accurate to be 
used on a routine basis, although remains an exciting area for future development and poses 
the possibility of automated reading. 
 
Figures:  
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